📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: EMcision

1.1 - Company Overview

EMcision Logo

EMcision

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medical devices for gastrointestinal applications, offering the Habib EndoHPB, an endoscopic bipolar RF probe developed to ablate tissue in the gastro-intestinal tract, and the Habib Endoblate, a bipolar RF probe for endoluminal ablation of gastrointestinal tumours.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to EMcision

Boston Biomedical Logo

Boston Biomedical

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on novel therapeutics to treat cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Boston Biomedical company profile →
Argos Therapeutics Logo

Argos Therapeutics

HQ: United States Website
  • Description: Provider of immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. Conducts clinical trial programs in cancer and HIV. Product candidates include AGS-0031 for metastatic renal cell carcinoma, AGS-0041 for HIV, and CD83.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Argos Therapeutics company profile →
Kymera Therapeutics Logo

Kymera Therapeutics

HQ: United States Website
  • Description: Provider of targeted protein degradation therapeutics, leveraging TPD to eliminate disease-causing proteins, developing investigational degraders KT-474 (IRAK4) in Phase 2 for hidradenitis suppurativa and atopic dermatitis; KT-333 (STAT3) in Phase 1 for hematological malignancies and solid tumors; and KT-253 (MDM2) in Phase 1 for high-grade myeloid malignancies, lymphomas, and solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kymera Therapeutics company profile →
Viracta Therapeutics Logo

Viracta Therapeutics

HQ: United States Website
  • Description: Provider of precision oncology therapies targeting virus-associated malignancies, including Nana-val (nanatinostat + valganciclovir) for relapsed/refractory EBV+ lymphoma (late-stage clinical) and recurrent/metastatic EBV+ solid tumors (early-stage clinical), alongside preclinical products for undisclosed indications and an expanded access policy for investigational treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viracta Therapeutics company profile →
Crescent Biopharma Logo

Crescent Biopharma

HQ: United States Website
  • Description: Provider of novel precision-engineered biologics targeting verified biology to treat solid tumors, originating from discoveries at Paragon Therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Crescent Biopharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for EMcision

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to EMcision

2.2 - Growth funds investing in similar companies to EMcision

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for EMcision

4.2 - Public trading comparable groups for EMcision

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to EMcision

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About EMcision

What does EMcision do?

EMcision is a provider of medical devices for gastrointestinal applications, offering the Habib EndoHPB, an endoscopic bipolar RF probe developed to ablate tissue in the gastro-intestinal tract, and the Habib Endoblate, a bipolar RF probe for endoluminal ablation of gastrointestinal tumours.

Who are EMcision's competitors?

EMcision's competitors and similar companies include Boston Biomedical, Argos Therapeutics, Kymera Therapeutics, Viracta Therapeutics, and Crescent Biopharma.

Where is EMcision headquartered?

EMcision is headquartered in United Kingdom.

How many employees does EMcision have?

EMcision has 1,000 employees 🔒.

When was EMcision founded?

EMcision was founded in 2010 🔒.

What sector and industry vertical is EMcision in?

EMcision is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for EMcision

Who are the top strategic acquirers in EMcision's sector and industry

Top strategic M&A buyers and acquirers in EMcision's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for EMcision?

Top strategic M&A buyers groups and sectors for EMcision include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in EMcision's sector and industry vertical

Which are the top PE firms investing in EMcision's sector and industry vertical?

Top PE firms investing in EMcision's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in EMcision's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in EMcision's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in EMcision's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to EMcision include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in EMcision's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for EMcision?

The key public trading comparables and valuation benchmarks for EMcision include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for EMcision for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for EMcision with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in EMcision's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for EMcision with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in EMcision's' sector and industry vertical?

Access recent funding rounds and capital raises in EMcision's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for EMcision